For: | Numata K, Luo W, Morimoto M, Kondo M, Kunishi Y, Sasaki T, Nozaki A, Tanaka K. Contrast enhanced ultrasound of hepatocellular carcinoma. World J Radiol 2010; 2(2): 68-82 [PMID: 21160920 DOI: 10.4329/wjr.v2.i2.68] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v2/i2/68.htm |
Number | Citing Articles |
1 |
David C. Wang, Hyun-Jung Jang, Tae Kyoung Kim. Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?. American Journal of Roentgenology 2020; 214(6): 1295 doi: 10.2214/AJR.19.21498
|
2 |
Ali F. AbuRahma, Shadi Abu-Halimah, Phillip J. Bendick. Noninvasive Vascular Diagnosis. 2022; : 1163 doi: 10.1007/978-3-030-60626-8_56
|
3 |
Craig S. Carlson, Ryunosuke Matsumoto, Koji Fushino, Miryu Shinzato, Nobuki Kudo, Michiel Postema. Nucleation threshold of carbon black ultrasound contrast agent. Japanese Journal of Applied Physics 2021; 60(SD): SDDA06 doi: 10.35848/1347-4065/abef0f
|
4 |
Ji Hye Min, Hyo Keun Lim, Sanghyeok Lim, Tae Wook Kang, Kyoung Doo Song, Seo-youn Choi, Hyunchul Rhim, Min Woo Lee. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clinical and Molecular Hepatology 2014; 20(1): 61 doi: 10.3350/cmh.2014.20.1.61
|
5 |
Ying Zhang, Kazushi Numata, Yuewu Du, Shin Maeda. Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.921667
|
6 |
Hironori TANAKA. Current role of ultrasound in the diagnosis of hepatocellular carcinoma. Choonpa Igaku 2021; 48(6): 341 doi: 10.3179/jjmu.JJMU.R.181
|
7 |
Naoki Hotta, Kazuo Masuko. Usefulness of new live 3D ultrasound probe during radiofrequency ablation in a case of hepatocellular carcinoma. Open Journal of Gastroenterology 2012; 2(01): 15 doi: 10.4236/ojgas.2012.21003
|
8 |
M. Sugano, Y. Negishi, Y. Endo‐Takahashi, N. Hamano, M. Usui, R. Suzuki, K. Maruyama, Y. Aramaki, M. Yamamoto. Gene delivery to periodontal tissue using Bubble liposomes and ultrasound. Journal of Periodontal Research 2014; 49(3): 398 doi: 10.1111/jre.12119
|
9 |
Hiromi Nihonmatsu, Kazushi Numata, Hiroyuki Fukuda, Katsuaki Tanaka, Mari Ooba, Shin Maeda. Low mechanical index contrast mode versus high mechanical index contrast mode: which is a more sensitive method for detecting Sonazoid microbubbles in the liver of normal subjects?. Journal of Medical Ultrasonics 2016; 43(2): 211 doi: 10.1007/s10396-015-0685-6
|
10 |
H Shi, Y Ong, A Gogna, N Venkatanarasimha, SK Sanamandra, S Leong, FG Irani, RH Lo, CW Too. Perfluorobutane contrast-enhanced ultrasonography: a new standard for ultrasonography-guided thermal ablation of sonographically occult liver tumours?. Singapore Medical Journal 2021; 62(10): 546 doi: 10.11622/smedj.2020061
|
11 |
Ali F. AbuRahma, Shadi J. Abu-Halimah, Phillip J. Bendick. Noninvasive Vascular Diagnosis. 2021; : 1 doi: 10.1007/978-3-030-49616-6_56-1
|
12 |
Yoshiteru Hao, Kazushi Numata, Tomohiro Ishii, Hiroyuki Fukuda, Shin Maeda, Masayuki Nakano, Katsuaki Tanaka. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(17): 3111-3121 doi: 10.3748/wjg.v23.i17.3111
|
13 |
Kenichi Takizawa, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Akito Nozaki, Satoshi Moriya, Tomohiro Ishii, Takashi Oshima, Hiroyuki Fukuda, Masahiro Okada, Shigeo Takebayashi, Shin Maeda, Katsuaki Tanaka. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma. European Journal of Radiology 2013; 82(9): 1471 doi: 10.1016/j.ejrad.2013.04.045
|
14 |
Ernesto Domenech, Juan de Dios Berná-Serna, Luis Polo, Manuel Reus, Juan de Dios Berná-Mestre, Manuel Canteras. Effect of SonoVue on the Synovial Membrane in Rabbit Knees. Journal of Ultrasound in Medicine 2011; 30(9): 1241 doi: 10.7863/jum.2011.30.9.1241
|
15 |
Yasuhide MITSUMOTO, Ryuuki MINAMI, Takahiro MORI, Takuya UCHIDA, Koji FUJITA, Yasuhiro KOMIYAMA, Hajime HONJYO, Hajime OHMI, Tadahiro YAMAKAWA. Application of GPS marker to the local treatment of hepatocellular carcinoma -GPS markers two-point method-. Choonpa Igaku 2011; 38(5): 585 doi: 10.3179/jjmu.38.585
|
16 |
|
17 |
Lee‐Shuan Lin, Cheng‐Shu Chung. Novel contrast agent Visphere™ is feasible for contrast‐enhanced ultrasonography in dogs. Veterinary Radiology & Ultrasound 2020; 61(4): 461 doi: 10.1111/vru.12869
|
18 |
Jeong Ah Hwang, Woo Kyoung Jeong, Hyo-Jin Kang, Eun Sun Lee, Hyun Jeong Park, Jeong Min Lee. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma. European Radiology 2022; 32(12): 8507 doi: 10.1007/s00330-022-08900-6
|
19 |
Haruo Miwa, Kazushi Numata, Kazuya Sugimori, Katsuyuki Sanga, Akane Hirotani, Shun Tezuka, Yoshihiro Goda, Kuniyasu Irie, Tomohiro Ishii, Takashi Kaneko, Katsuaki Tanaka, Shin Maeda. Differential diagnosis of gallbladder polypoid lesions using contrast-enhanced ultrasound. Abdominal Radiology 2019; 44(4): 1367 doi: 10.1007/s00261-018-1833-4
|
20 |
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers 2021; 13(4): 790 doi: 10.3390/cancers13040790
|
21 |
Kazushi Numata, Hiroyuki Fukuda, Manabu Morimoto, Akito Nozaki, Masaaki Kondo, Akinori Nozawa, Masayuki Nakano, Katsuaki Tanaka. Early hepatocellular carcinoma: findings of contrast-enhanced sonography. Kanzo 2011; 52(7): 429 doi: 10.2957/kanzo.52.429
|
22 |
Francesco Bellissimo, Marilia Rita Pinzone, Bruno Cacopardo, Giuseppe Nunnari. Diagnostic and therapeutic management of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12003-12021 doi: 10.3748/wjg.v21.i42.12003
|
23 |
Mark Abel, Wey Chyi Teoh, Edward Leen. Contrast Evaluation of Liver Masses. Ultrasound Clinics 2014; 9(4): 605 doi: 10.1016/j.cult.2014.07.003
|
24 |
Kazushi Numata, Hiroyuki Fukuda, Manabu Morimoto, Masaaki Kondo, Akito Nozaki, Takashi Oshima, Masahiro Okada, Shigeo Takebayashi, Shin Maeda, Katsuaki Tanaka. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. European Journal of Radiology 2012; 81(10): 2746 doi: 10.1016/j.ejrad.2011.11.052
|
25 |
Kazuya TAKAGI, Satoshi KONDO, Kensuke NAKAMURA, Mitsuyoshi TAKIGUCHI. Lesion Type Classification by Applying Machine-Learning Technique to Contrast-Enhanced Ultrasound Images. IEICE Transactions on Information and Systems 2014; (11): 2947 doi: 10.1587/transinf.2013EDP7464
|
26 |
Yosuke Kunishi, Kazushi Numata, Manabu Morimoto, Masahiro Okada, Tetsuji Kaneko, Shin Maeda, Katsuaki Tanaka. Efficacy of Fusion Imaging Combining Sonography and Hepatobiliary Phase MRI With Gd-EOB-DTPA to Detect Small Hepatocellular Carcinoma. American Journal of Roentgenology 2012; 198(1): 106 doi: 10.2214/AJR.10.6039
|
27 |
Taehyuk Ham, Joo Hee Jeon, Younghoon Roh, Sungwook Lee, Sangyoon Lee, Heejin Kwon, Jin Han Cho. A novel method to determine hepatic segments using Sonazoid, an ultrasound contrast agent. Ultrasonography 2020; 39(1): 94 doi: 10.14366/usg.19020
|
28 |
Kazushi Numata, Hiroyuki Fukuda, Haruo Miwa, Tomohiro Ishii, Satoshi Moriya, Masaaki Kondo, Akito Nozaki, Manabu Morimoto, Masahiro Okada, Shigeo Takebayashi, Shin Maeda, Akinori Nozawa, Masayuki Nakano, Katsuaki Tanaka. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. European Journal of Radiology 2014; 83(1): 95 doi: 10.1016/j.ejrad.2013.09.025
|
29 |
Zaya Duisyenbi, Kazushi Numata, Hiromi Nihonmatsu, Hiroyuki Fukuda, Makoto Chuma, Masaaki Kondo, Akito Nozaki, Katsuaki Tanaka, Shin Maeda. Comparison Between Low Mechanical Index and High Mechanical Index Contrast Modes of Contrast‐Enhanced Ultrasonography: Evaluation of Perfusion Defects of Hypervascular Hepatocellular Carcinomas During the Post–Vascular Phase. Journal of Ultrasound in Medicine 2019; 38(9): 2329 doi: 10.1002/jum.14926
|
30 |
Katsutoshi Sugimoto, Fuminori Moriyasu, Shin Kono, Motoko Sasaki, Yasuni Nakanuma, Yasuharu Imai. A case of mucinous cystic neoplasm of the liver: description of Sonazoid-enhanced ultrasound imaging and histopathologic findings. Journal of Medical Ultrasonics 2013; 40(3): 243 doi: 10.1007/s10396-012-0422-3
|
31 |
Hironori Tanaka. Current role of ultrasound in the diagnosis of hepatocellular carcinoma. Journal of Medical Ultrasonics 2020; 47(2): 239 doi: 10.1007/s10396-020-01012-y
|
32 |
Ahmed Alzaraa, Gianpiero Gravante, Wen Yuan Chung, Dhya Al‐Leswas, Bruno Morgan, Ashley Dennison, David Lloyd. Contrast‐enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions. Hepatology Research 2013; 43(8): 809 doi: 10.1111/hepr.12044
|
33 |
Kazushi Numata, Katsuaki Tanaka. 1. Diagnosis of Hepatocellular Carcinoma by Ultrasonography. Nihon Naika Gakkai Zasshi 2014; 103(1): 44 doi: 10.2169/naika.103.44
|
34 |
Federica Maione, Enrico Giraudo. Mouse Models of Cancer. Methods in Molecular Biology 2015; 1267: 349 doi: 10.1007/978-1-4939-2297-0_17
|
35 |
Hiroshi Matsubara, Hirotaka Suzuki, Takehito Naitoh, Fumihiro Urano, Nobuyuki Kiura. Usefulness of contrast-enhanced ultrasonography for biliary tract disease. Journal of Medical Ultrasonics 2023; doi: 10.1007/s10396-023-01338-3
|
36 |
Wei Zhang, Yilun Liu, Qiong Wu, Xiaoer Wei, Beibei Liu, Qiong Jiao, Rui Zhang, Bing Hu, Yi Li, Tao Ying. Pitfalls and strategies of Sonazoid enhanced ultrasonography in differentiating metastatic and benign hepatic lesions. Clinical Hemorheology and Microcirculation 2024; 86(4): 467 doi: 10.3233/CH-231995
|
37 |
Ali F. AbuRahma, Phillip J. Bendick. Noninvasive Vascular Diagnosis. 2017; : 749 doi: 10.1007/978-3-319-54760-2_56
|
38 |
So Jung Lee, Hyung Jin Won, Kyung Won Kim, Yong Moon Shin, Pyo Nyun Kim. Value of contrast‐enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation. Journal of Clinical Ultrasound 2017; 45(7): 383 doi: 10.1002/jcu.22469
|
39 |
Adebayo Laniyonu, Yanli Ouyang, Jonathan Cohen, Sunny Awe, Olayinka Dina, Siham Biade, Sally Hargus, Tushar Kokate. Molecular Imaging. 2021; : 717 doi: 10.1016/B978-0-12-816386-3.00039-9
|
40 |
Hitoshi Maruyama, Tadashi Sekimoto, Osamu Yokosuka. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience. Journal of Gastroenterology 2016; 51(5): 421 doi: 10.1007/s00535-015-1151-3
|
41 |
Richard S. Young, Mohammed Aldiwani, Abdul R. Hakeem, Amit Nair, Ashley Guthrie, Judy Wyatt, Darren Treanor, Gareth Morris‐Stiff, Rebecca L. Jones, K. Rajendra Prasad. Pre‐liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation?. HPB 2013; 15(6): 418 doi: 10.1111/hpb.12008
|
42 |
Nobuyuki Toshikuni, Hisakazu Shiroeda, Kazuaki Ozaki, Yasuhiro Matsue, Takahiro Minato, Tomoe Nomura, Nobuhiko Hayashi, Tomiyasu Arisawa, Mikihiro Tsutsumi. Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma. Radiology and Oncology 2013; 47(3): 224 doi: 10.2478/raon-2013-0033
|
43 |
Akiko Hayakawa, Kenji Abe, Masatoshi Tanigawa, Megumi Takahashi, Yasuhiko Uchida, Yukihiro Okutani. The safety and the efficacy of radiofrequency ablation (RFA) guided by contrast-enhanced sonography with Perflubutane microbubbles for hepatic lesion in clinical practice. Kanzo 2012; 53(11): 721 doi: 10.2957/kanzo.53.721
|
44 |
Jae Young Lee, Yasunori Minami, Byung Ihn Choi, Won Jae Lee, Yi-Hong Chou, Woo Kyoung Jeong, Mi-Suk Park, Nobuki Kudo, Min Woo Lee, Ken Kamata, Hiroko Iijima, So Yeon Kim, Kazushi Numata, Katsutoshi Sugimoto, Hitoshi Maruyama, Yasukiyo Sumino, Chikara Ogawa, Masayuki Kitano, Ijin Joo, Junichi Arita, Ja-Der Liang, Hsi-Ming Lin, Christian Nolsoe, Odd Helge Gilja, Masatoshi Kudo. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography 2020; 39(3): 191 doi: 10.14366/usg.20057
|
45 |
Jeong Ah Hwang, Woo Kyoung Jeong, Ji Hye Min, Yeun-Yoon Kim, Nam Hun Heo, Hyo Keun Lim. Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma. Ultrasonography 2021; 40(4): 486 doi: 10.14366/usg.20120
|
46 |
Ali F. AbuRahma, Phillip J. Bendick. Noninvasive Vascular Diagnosis. 2013; : 679 doi: 10.1007/978-1-4471-4005-4_54
|
47 |
Tomohiro Ishii, Kazushi Numata, Yoshiteru Hao, Nobutaka Doba, Koji Hara, Masaaki Kondo, Katsuaki Tanaka, Shin Maeda. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. European Journal of Radiology 2017; 89: 234 doi: 10.1016/j.ejrad.2016.12.018
|
48 |
Brian P. Davidson, James Hodovan, Michael E. Layoun, Harsh Golwala, Firas Zahr, Jonathan R. Lindner. Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia. Journal of the American College of Cardiology 2021; 78(20): 1990 doi: 10.1016/j.jacc.2021.08.068
|
49 |
Haruo Miwa, Kazushi Numata, Kazuya Sugimori, Takashi Kaneko, Shin Maeda. Vascular evaluation using transabdominal ultrasound for gallbladder polyps. Journal of Medical Ultrasonics 2021; 48(2): 159 doi: 10.1007/s10396-020-01008-8
|
50 |
Hiroshi Takahashi, Katsutoshi Sugimoto, Naohisa Kamiyama, Kentaro Sakamaki, Tatsuya Kakegawa, Takuya Wada, Yusuke Tomita, Masakazu Abe, Yu Yoshimasu, Hirohito Takeuchi, Takao Itoi. Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase. Diagnostics 2022; 12(1): 141 doi: 10.3390/diagnostics12010141
|